A novel prognostic signature contributes to precision treatment in colon adenocarcinoma with KRAS mutation

克拉斯 列线图 结直肠癌 比例危险模型 医学 肿瘤科 内科学 腺癌 癌症 接收机工作特性 基因签名 癌症研究 生物 基因 遗传学 基因表达
作者
Weiwei Dong,He Zhang,Qingyan Li,Na Guan,Sheng Wang,Huixia Zhao,Xiyan Zhang,Zhiyan Zeng,Yanyan Hu,Qiuwen Li,Jingwen Yang,Zihuan Ma,Mei‐Ling Chen,Wenhua Xiao
出处
期刊:European Journal of Cancer Prevention [Lippincott Williams & Wilkins]
卷期号:32 (6): 557-565 被引量:1
标识
DOI:10.1097/cej.0000000000000819
摘要

Approximately 40% of colon cancer harbor Kirsten rat sarcoma viral oncogene ( KRAS ) mutations, but the prognostic value of KRAS mutations in colon cancer is still controversial.We enrolled 412 colon adenocarcinoma (COAD) patients with KRAS mutations, 644 COAD patients with KRAS wild-type and 357 COAD patients lacking information on KRAS status from five independent cohorts. A random forest model was developed to estimate the KRAS status. The prognostic signature was established using least absolute shrinkage and selection operator-Cox regression and evaluated by Kaplan-Meier survival analysis, multivariate-Cox analysis, receiver operating characteristic curve and nomogram. The expression data of KRAS -mutant COAD cell lines from the Cancer Cell Line Encyclopedia database and the corresponding drug sensitivity data from the Genomics of Drug Sensitivity in Cancer database were used for potential target and agent exploration.We established a 36-gene prognostic signature classifying the KRAS -mutant COAD as high and low risk. High risk patients had inferior prognoses compared to those with low risk, while the signature failed to distinguish the prognosis of COAD with KRAS wild-type. The risk score was the independent prognostic factor for KRAS -mutant COAD and we further fabricated the nomograms with good predictive efficiency. Moreover, we suggested FMNL1 as a potential drug target and three drugs as potential therapeutic agents for KRAS -mutant COAD with high risk.We established a precise 36-gene prognostic signature with great performance in prognosis prediction of KRAS -mutant COAD providing a new strategy for personalized prognosis management and precision treatment for KRAS -mutant COAD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sgt完成签到,获得积分10
刚刚
坦率夕阳完成签到,获得积分10
1秒前
2秒前
avc完成签到,获得积分10
2秒前
haha完成签到,获得积分10
3秒前
大模型应助拟好啊采纳,获得10
3秒前
5秒前
CipherSage应助uppnice采纳,获得10
7秒前
独白发布了新的文献求助10
7秒前
8秒前
avc发布了新的文献求助10
9秒前
11秒前
SciGPT应助迟迟采纳,获得10
11秒前
11秒前
无生发布了新的文献求助10
13秒前
orixero应助爱学习的小花生采纳,获得10
13秒前
ywl发布了新的文献求助10
17秒前
量子星尘发布了新的文献求助10
18秒前
梦鱼完成签到 ,获得积分10
19秒前
21秒前
22秒前
研友_VZG7GZ应助lzz采纳,获得10
22秒前
HQK完成签到,获得积分10
24秒前
阳佟冬卉完成签到,获得积分10
24秒前
大个应助ywl采纳,获得10
24秒前
迟迟发布了新的文献求助10
26秒前
joshar发布了新的文献求助10
29秒前
独白完成签到,获得积分10
30秒前
FashionBoy应助zzbyxh采纳,获得10
30秒前
yx_cheng应助科研通管家采纳,获得10
30秒前
科研通AI5应助科研通管家采纳,获得50
30秒前
Hello应助科研通管家采纳,获得10
30秒前
共享精神应助科研通管家采纳,获得10
30秒前
烟花应助科研通管家采纳,获得10
30秒前
30秒前
华仔应助科研通管家采纳,获得10
30秒前
30秒前
30秒前
30秒前
33秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975661
求助须知:如何正确求助?哪些是违规求助? 3520000
关于积分的说明 11200535
捐赠科研通 3256410
什么是DOI,文献DOI怎么找? 1798247
邀请新用户注册赠送积分活动 877490
科研通“疑难数据库(出版商)”最低求助积分说明 806390